Zosyn- Drug Insight, 2018

IntroductionDelveInsight’s pharmaceuticals report, "Zosyn Drug Insight, 2018" highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location.

The report covers the Global Market Assessment of the Zosyn covering the historical global sales and also provides the Zosyn sales estimation during the forecasted period (2018-2020). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country.

In addition to this, the report also provides the SWOT analysis for Zosyn and emerging therapies in this space.

MethodologyThe report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight`s team of industry experts.Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope• A review of the Zosyn, based on information derived from company and industry-specific sources• Product details on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification• Coverage of the Drug Master Files and API Manufacturers by country• Patent Expiry Timeline and Exclusivity Details• Route of Synthesis of the API• Forecasted Sales Figure from 2018-2020• Market competition and emerging therapies• SWOT Analysis

Reasons to Buy• Establish a comprehensive understanding of Zosyn• Access to drug`s API manufacturers details to devise API procurement strategy for generic development• Plan developmental timelines around drug`s patents for the major markets- US and EU• Understand Zosyn`s current and future growth through its historical and forecasted sales• Identify and understand the current in-market competitors for the drug• Identify the product attributes and use it for target finding, drug repurposing, and precision medicine• Identify and plan ahead for prospective emerging players and their products operating in the same space as the drug• Identify opportunities in the same area as Zosyn with DelveInsight`s SWOT analysis

• The global biological safety testing market should reach $13.1 billion by 2022 from $5.1 billion in 2017 at a compound annual growth rate (CAGR) of 20.9%, from 2017 to 2022. • The analytical testing services segment of global biological safety testing market is expected to grow from $1.9 billion in 2017 to $4.9 billion in 2022 at a CAGR...

About Acromegaly and Gigantism Drugs The acromegaly and gigantism are GH-related diseases. Acromegaly disease occurs in adults while gigantism occurs in children. Technavio’s analysts forecast the global acromegaly and gigantism drugs market to grow at a CAGR of 3.03% during the period 2018-2022. Covered...

About Krabbe Disease Treatment Krabbe disease is a rare inherited genetic disorder that affects the nervous system. It is usually caused by the deficiency of the galactosylceramidase (GLC) enzyme. The disease is inherited in an autosomal recessive pattern. Technavio’s analysts forecast the global krabbe disease...

About Infertility Drugs Infertility can be defined as an inability of a person to reproduce through natural means. Infertility can occur in any of the two genders, i.e., male and female. Technavio’s analysts forecast the global infertility drugs market to grow at a CAGR of 4.67% during the period 2018-2022. Covered...